Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HK40092066A - Inhibitors of fibroblast growth factor receptor kinases - Google Patents
[go: Go Back, main page]

HK40092066A - Inhibitors of fibroblast growth factor receptor kinases - Google Patents

Inhibitors of fibroblast growth factor receptor kinases Download PDF

Info

Publication number
HK40092066A
HK40092066A HK62023080625.4A HK62023080625A HK40092066A HK 40092066 A HK40092066 A HK 40092066A HK 62023080625 A HK62023080625 A HK 62023080625A HK 40092066 A HK40092066 A HK 40092066A
Authority
HK
Hong Kong
Prior art keywords
inhibitors
growth factor
factor receptor
fibroblast growth
receptor kinases
Prior art date
Application number
HK62023080625.4A
Other languages
Chinese (zh)
Inventor
Stephen W. Kaldor
John Tyhonas
Eric A. Murphy
Toufike Kanouni
Lee D. Arnold
Robert Kania
Jason M. Cox
Original Assignee
Kinnate Biopharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinnate Biopharma Inc. filed Critical Kinnate Biopharma Inc.
Publication of HK40092066A publication Critical patent/HK40092066A/en

Links

HK62023080625.4A 2020-06-05 2021-06-04 Inhibitors of fibroblast growth factor receptor kinases HK40092066A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/035,155 2020-06-05
US63/106,812 2020-10-28

Publications (1)

Publication Number Publication Date
HK40092066A true HK40092066A (en) 2023-12-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3969442A4 (en) Inhibitors of fibroblast growth factor receptor kinases
CA3243183A1 (en) Inhibitors of ras oncoproteins
EP4225742A4 (en) 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases
IL309447A (en) Pharmaceutical compositions of an epidermal growth factor receptor inhibitor
EP3999064A4 (en) Inhibitors of tyrosine kinase
HK40092066A (en) Inhibitors of fibroblast growth factor receptor kinases
CA3303605A1 (en) Epidermal growth factor receptor inhibitors
AU2023902843A0 (en) Epidermal growth factor receptor inhibitors
CA3243450A1 (en) Imidazopyridine inhibitors of tyrosine kinase
EP4161488A4 (en) Rho kinase inhibitor releasing implants and related methods of use
HK40126792A (en) Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
CA3259492A1 (en) Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
HK40118888A (en) Inhibitors of met kinase
HK40085112A (en) Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
CA3278159A1 (en) Inhibitors of mptp
CA3278918A1 (en) Inhibitors of mptp
HK40123313A (en) Pikfyve kinase inhibitors
HK40097580A (en) 7-azaindole compounds for inhibition of bcr-abl tyrosine kinases
HK40082084A (en) Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
CA3262493A1 (en) Preparation and use of quinazolinone derivative as kinase inhibitor
HK40118084A (en) Preparation and use of quinazolinone derivative as kinase inhibitor
HK40097063A (en) 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases
HK40118285A (en) Inhibitors of cdk4/6 kinase
HK40120770A (en) Inhibitors of mek kinase
CA3280368A1 (en) Use of tyrosine kinase inhibitor